TGen-Riddell partnership could help lead to advanced methods of injury and disease detectionContinue reading
Category Archives: AZBio News
Seven Arizona Bio Startups Named Flinn Foundation Bioscience Entrepreneurship Program Winners
Seven Arizona bioscience startup firms were competitively selected to participate in the 2017 Flinn Foundation Bioscience Entrepreneurship Program, which was established to foster entrepreneurship and help early-stage bioscience companies develop into successful and sustainable businesses in Arizona.
SynCardia Names New VP of Manufacturing and Facilities
Brian Brogie has more than 30 years of manufacturing, process improvement and supplier management experience in highly regulated industries, including medical devices. Continue reading
Axolotl Biologix Appoints Robert S. Kellar, Ph.D., as Chief Science Officer
Axolotl Biologix, an innovator in regenerative medicine technologies that improve patient outcomes with less pain and lower costs, today announced the appointment of Robert S. Kellar, Ph.D., as Chief Science Officer.Continue reading
Axolotl Biologix Signs Exclusive Worldwide License for Protein Genomics’ Elastatropin®
Axolotl Biologix Signs Exclusive Worldwide License for Protein Genomics’ Elastatropin® to Drive Innovation in Regenerative Medicine Products for Wound CareContinue reading
Arizona Health Innovations
AZBio President & CEO, Joan Koerber-Walker, shares highlights of health innovations being discovered, developed and delivered in Arizona with Members of the House Health Committee in the Arizona House of Representatives on March 9, 2017.Continue reading
New indicators to aid Crohn’s disease diagnosis and treatment
The diagnosis, understanding and management of Crohn’s disease may have just received a helping hand from a joint Biodesign Institute and Mayo Clinic study aimed at developing a better blood test for the disease.
Breakthrough Lyme disease test is the ‘next generation’ of diagnostics
Crowd funding campaign launches to start clinical study for TGen-developed diagnostic testContinue reading
HTG Molecular Diagnostics Appoints New Chair of the Board of Directors
HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, today announced that Ann F. Hanham, Ph.D., a director since August 2016, has been appointed to the Chair of the company’s board of directors.Continue reading